Clinexel Life Sciences Pvt Ltd is a pharmaceutical startup based in India, founded in 2019. The company positions itself as a full-service Clinical Research Organization (CRO), specializing in Clinical Research and Pharmacovigilance. Offering end-to-end services for NCEs & Biologicals, including Phase 1, 2 & 3 clinical trials, regulatory approvals, site selection, monitoring, logistics & CT supplies, patient recruitment strategies, data management, statistical analysis, CSR writing, PMCF studies, and writing Clinical Evaluation Reports (CERs) for CE marking and renewals under the EU MDR for medical device projects, Clinexel demonstrates a comprehensive portfolio. With a team consisting of 20 qualified, trained and experienced professionals (Physicians and Pharmacists), the company provides services to small and mid-size Pharmabiotech and Medical Device companies globally, including the USA, Europe, and UK. The team is well-versed in ICH-GCP and Indian regulations, with extensive monitoring experience in India and membership in AICROS. Although specific financial details are not available, Clinexel's ability to offer cost-efficient global clinical trials for clients while ensuring high quality and local expertise in each region presents an attractive investment opportunity for venture capitalists interested in the pharmaceutical industry. With a focus on new chemical entities, biosimilars, and complex generics, the company's capabilities and expertise make it a promising entity for potential investment.
There is no investment information
No recent news or press coverage available for CLINEXEL.